-+ 0.00%
-+ 0.00%
-+ 0.00%

BRISTOL-MYERS SQUIBB SPOKESPERSON - IMPLEMENTED A VOLUNTARY PAUSE TO REVIEW CLINICAL DATA ACROSS OUR ZOLA-CEL PROGRAM

Reuters·09/01/2026 11:48:09

Please log in to view news